Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.

@article{Hershman2014PreventionAM,
  title={Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.},
  author={D. Hershman and C. Lacchetti and R. Dworkin and Ellen M. Lavoie Smith and J. Bleeker and G. Cavaletti and C. Chauhan and Patrick M. Gavin and A. Lavino and M. Lustberg and J. Paice and B. Schneider and M. Smith and T. Smith and S. Terstriep and N. Wagner-Johnston and K. Bak and C. Loprinzi},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2014},
  volume={32 18},
  pages={
          1941-67
        }
}
  • D. Hershman, C. Lacchetti, +15 authors C. Loprinzi
  • Published 2014
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • PURPOSE To provide evidence-based guidance on the optimum prevention and treatment approaches in the management of chemotherapy-induced peripheral neuropathies (CIPN) in adult cancer survivors. METHODS A systematic literature search identified relevant, randomized controlled trials (RCTs) for the treatment of CIPN. Primary outcomes included incidence and severity of neuropathy as measured by neurophysiologic changes, patient-reported outcomes, and quality of life. RESULTS A total of 48 RCTs… CONTINUE READING
    704 Citations

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    The main objective of this clinical trial is to evaluate the effectiveness and cost-effectiveness of adding ozone therapy to the clinical management of patients with pain secondary… Expand
    ConditionsChemotherapy-induced Peripheral Neuropathy, Pain, Neuropathic, Pain Syndrome
    InterventionDrug
    INTERVENTIONAL CLINICAL TRIAL
    This study will determine the efficacy of cryotherapy to prevent paclitaxel-induced peripheral neuropathy and nail changes in women with breast cancer.  
    ConditionsCryotherapy Effect, Nail Toxicity, Peripheral Neuropathy
    InterventionOther
    INTERVENTIONAL CLINICAL TRIAL
    This study aimed to assess the efficacy of cryotherapy in controlling Peripheral Neuropathy in cancer children  
    ConditionsCancer
    InterventionOther
    Chemotherapy-induced peripheral neuropathy clinical trials
    • 12
    Management of Chronic Pain in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline.
    • J. Paice, R. Portenoy, +13 authors E. Bruera
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2016
    • 165
    • PDF
    Instruments for Assessing Chemotherapy-Induced Peripheral Neuropathy: A Review of the Literature.
    • 10
    Chemotherapy-induced peripheral neuropathy: bench to clinical practice

    References

    SHOWING 1-10 OF 108 REFERENCES
    The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.
    • 187
    • Highly Influential
    Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients
    • 78
    The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial
    • 126
    Chemotherapy‐Induced Peripheral Neuropathy: Prevention and Treatment
    • 200
    Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools.
    • 190
    Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer.
    • 64
    NCCN task force report: management of neuropathy in cancer.
    • 164
    • PDF